SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-12-002303
Filing Date
2012-01-13
Accepted
2012-01-13 15:40:35
Documents
1
Group Members
DR. JAMES I. HEALYDR. MICHAEL F. POWELLERIC P. BUATOISSOFINNOVA MANAGEMENT VII, L.L.C.

Document Format Files

Seq Description Document Type Size
1 AMENDED TRANSACTION REPORT v245468_13da.htm SC 13D/A 126683
  Complete submission text file 0001144204-12-002303.txt   128250
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Subject) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85614 | Film No.: 12526553
SIC: 2834 Pharmaceutical Preparations

Mailing Address 140 GEARY ST 10TH FL SAN FRANCISCO CA 94108
Business Address 140 GEARY ST 10TH FL SAN FRANCISCO CA 94108 415-228-3390
SOFINNOVA VENTURE PARTNERS VII L P (Filed by) CIK: 0001380734 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A